(P-1447) T-Cell Responses Following Two Doses of mRNA-1345 in Adult Solid Organ Transplant Recipients

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Erick F. Mayer, MD (he/him/his)

Director, Clinical Development
Moderna, Inc.
Cambridge, MA, United States

Cameron R. Wolfe, MBBS, MPH, FAST, FIDSA

Professor of Medicine
Duke University
Durham, NC, United States
Ann R. Falsey, MD

Dr
University of Rochester School of Medicine
Rochester, New York, United States
CG

Christina Grassi, MD

Moderna, Inc.
Cambridge, Massachusetts, United States
AC

Avi Collins, BScN

Moderna, Inc.
Cambridge, Massachusetts, United States
MH

Md Hasan, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
HK

Hsiaohsuan Kuo, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
SM

Shannon McGrath, MS

Director of Clinical Cytometry
Moderna, Inc.
Norwood, Massachusetts, United States
AK

Archana Kapoor, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
XC

Xiaolin Chang, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
XC

Xing Chen, Sc.D.

Moderna, Inc.
Cambridge, Massachusetts, United States
LL

Lan Lan, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
SS

Sonia K. Stoszek, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
EW

Eleanor Wilson, MD, MHS

Moderna, Inc.
Cambridge, Massachusetts, United States
JG

Jaya Gowami, MD

Moderna, Inc.
Cambridge, Massachusetts, United States
RD

Rituparna Das, M.D.

Moderna, Inc.
Cambridge, Massachusetts, United States
FP

Frances Priddy, MD, MPH (she/her/hers)

Executive Director, Clinical Development
Moderna, Inc.
Cambridge, Massachusetts, United States